![](/img/cover-not-exists.png)
Protect-1, a prospective randomized oral therapy evaluation of CCX282-B (Traficet-EN) in Crohnʼs disease trial
Bekker, P, Petryka, R, Vanasek, T, Niv, Y, Marlicz, K, Haagen-Nielsen, O, Dahelrup, J, Dotan, I, Compel, V, Keshav, S, Schall, TVolume:
14
Language:
english
Journal:
Inflammatory Bowel Diseases
DOI:
10.1097/00054725-200801001-00036
Date:
January, 2008
File:
PDF, 43 KB
english, 2008